News
Here you will find all the news about PhinC Development. We keep you informed about our latest events, our publications, our partnerships and our progress in terms of R&D…
Keep up to date with the latest news
[Webinar] Translational Mechanistic Modeling : Applications for ADCs
PhinC Development is pleased to host an exclusive webinar dedicated to Translational Mechanistic Modeling: Applications for Antibody Drug Conjugates (ADCs). Discover how Model-Informed Drug Development (MIDD) strategies can accelerate and de-risk ADC programs.
New article: Prediction of a CLDN18.2 Targeted Antibody Drug Conjugate Pharmacokinetics in Cancer Patients Using PBPK Modeling and Simulation
A first-in-class PBPK model for CLDN18.2-targeted ADCs using PK-Sim® and MoBi®. Read and discover the full article!
FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
The FDA is taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods.
New article: Unlock the power of PBPK Prediction!
In the ever-evolving landscape of pharmaceutical research, the quest for developing safer and more effective drugs is a continuous endeavor.
Modeling & Simulation integrated in drug development
Modeling and simulation play an increasingly crucial role in the development of drug candidates.
10 good reasons to use modeling and simulation
Modeling expertise is an essential building block for an optimal drug development strategy.